Skip to main content
Premium Trial:

Request an Annual Quote

NSF Awards $2.5M for Zygomycetes Studies

NEW YORK (GenomeWeb) – The National Science Foundation has awarded $2.5 million to researchers from 11 institutions to conduct studies, including sequencing-based analysis, of the evolution of zygomycetes.

Zygomycetes are fungi that are thought to be among the first organisms on Earth and play a variety of roles. They include molds that colonize bread and fruits, and others that attack insects.

They also are credited with helping to facilitate the evolution of land plants and play a role in human health. According to the grant abstract, the research project "[e]xpanding and maintaining expertise on these fungi is critical for the field of biology, human health, and productivity," and food safety.

In the current project, the researchers will use sequencing, bioimaging, metagenomic technologies, and other tools to build a better understanding of the fungi. Involved in the research are scientists from the University of Florida; the University of California, Riverside; Oregon State University; the University of Michigan; Arizona State University; the University of British Columbia; the University of Kansas; Boise State University; Duke University; the University of Ottawa; and the US Department of Agriculture's Agricultural Research Service.

"By gathering orders of magnitude more genome-scale data and integrating it with biochemical, morphological, subcellular, and fossil data layers, this elusive region of the fungal genealogy of life will be illuminated and will provide a foundation for broad-scale biological research" the researchers said in the grant abstract.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.